• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗器械不良反应报告中的障碍:一项文献综述。

Barriers in reporting adverse effects of medical devices: a literature review.

作者信息

Kaur Sukhpreet, Gandhi Ayush, Sandhu Sahibjot Kaur, Baldi Ashish

机构信息

Dasmesh College of Pharmacy, Faridkot, Punjab, India.

Shri Guru Ram Das College of Medical Sciences and Research, Amritsar, Punjab, India.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1145-1153. doi: 10.1007/s00210-024-03431-x. Epub 2024 Sep 11.

DOI:10.1007/s00210-024-03431-x
PMID:39259332
Abstract

Medical devices play an essential role in the delivery of healthcare but its use is not entirely risk free. There are several instances where it causes mortality or morbidity among users. It is important to evaluate the risks involved at every stage of its application to bring improvement in the standard of healthcare. For the purpose Materiovigilance Program of India was launched on July 6, 2015. Despite these efforts, available data suggests that reporting of adverse events is very low. The present study aims to identify barriers that influence the reporting of adverse events of medical devices and outline a strategy to overcome these barriers. Systemic review method has been adopted to achieve these ends. Thirty-one papers have been selected based on the inclusion criteria related to objective of the study. Lack of awareness, attitude, and resources are found to be major barriers at the individual level for not reporting adverse effects of medical devices. The organizational factors such as hierarchical set up, lack of time and incentives, and furthermore lack of industry responsiveness have been identified as prominent barriers to the reporting of adverse events. In order to improve the reporting level, it is important to make access and contact easier with the reporting system. Engaging healthcare professionals at various levels by acknowledging and appreciating their contribution. The adverse events of medical devices should not be restricted to physicians; only rather other health care professional such as nurses, pharmacists, and technicians should also be encouraged to report any adverse event of medical devices.

摘要

医疗设备在医疗保健服务中发挥着至关重要的作用,但其使用并非完全没有风险。在一些情况下,它会导致使用者死亡或发病。在其应用的每个阶段评估所涉及的风险对于提高医疗保健标准很重要。为此,印度于2015年7月6日启动了医疗器械警戒计划。尽管做出了这些努力,但现有数据表明不良事件的报告率非常低。本研究旨在确定影响医疗器械不良事件报告的障碍,并概述克服这些障碍的策略。已采用系统评价方法来实现这些目标。根据与研究目标相关的纳入标准,选择了31篇论文。在个人层面,缺乏意识、态度和资源被发现是不报告医疗器械不良反应的主要障碍。组织因素,如层级设置、缺乏时间和激励措施,以及行业缺乏响应能力,已被确定为不良事件报告的突出障碍。为了提高报告水平,重要的是使报告系统的访问和联系更加便捷。通过认可和赞赏各级医疗保健专业人员的贡献来吸引他们参与。医疗器械的不良事件不应仅限于医生;相反,还应鼓励其他医疗保健专业人员,如护士、药剂师和技术人员报告医疗器械的任何不良事件。

相似文献

1
Barriers in reporting adverse effects of medical devices: a literature review.医疗器械不良反应报告中的障碍:一项文献综述。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1145-1153. doi: 10.1007/s00210-024-03431-x. Epub 2024 Sep 11.
2
Sexual Harassment and Prevention Training性骚扰与预防培训
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Professional, structural and organisational interventions in primary care for reducing medication errors.在初级保健中采取专业、结构和组织干预措施以减少用药错误。
Cochrane Database Syst Rev. 2017 Oct 4;10(10):CD003942. doi: 10.1002/14651858.CD003942.pub3.
5
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
6
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
9
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
10
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.

引用本文的文献

1
Strengthening Dental Materiovigilance: A Review of International Reporting Frameworks.加强牙科药物警戒:国际报告框架综述
Int Dent J. 2025 Aug 6;75(5):100943. doi: 10.1016/j.identj.2025.100943.

本文引用的文献

1
Pharmacovigilance and spontaneous adverse drug reaction reporting: Challenges and opportunities.药物警戒与自发药品不良反应报告:挑战与机遇
Perspect Clin Res. 2022 Oct-Dec;13(4):177-179. doi: 10.4103/picr.picr_169_22. Epub 2022 Sep 27.
2
Post-market surveillance of medical devices: A review.医疗器械上市后监测:综述。
Technol Health Care. 2022;30(6):1315-1329. doi: 10.3233/THC-220284.
3
Barriers and facilitators to reporting medical device-related pressure ulcers: A qualitative exploration of international practice.
医疗器械相关性压力性溃疡报告的障碍和促进因素:国际实践的定性探索。
Int J Nurs Stud. 2022 Nov;135:104326. doi: 10.1016/j.ijnurstu.2022.104326. Epub 2022 Jul 19.
4
Materiovigilance Programme of India: Current status and way forward.印度药物警戒计划:现状与未来方向。
Indian J Pharmacol. 2022 May-Jun;54(3):221-225. doi: 10.4103/ijp.ijp_837_21.
5
Awareness, attitude, and practice of materiovigilance among medical professionals at a tertiary care institute of national importance: A cross-sectional study.一所具有国家重要性的三级医疗机构中医疗专业人员对药物警戒的认知、态度和实践:一项横断面研究。
Perspect Clin Res. 2022 Apr-Jun;13(2):94-98. doi: 10.4103/picr.PICR_187_19. Epub 2021 Jan 15.
6
Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death.美国食品和药物管理局医疗器械不良事件报告中除死亡以外其他类别的死亡报告情况。
JAMA Intern Med. 2021 Sep 1;181(9):1217-1223. doi: 10.1001/jamainternmed.2021.3942.
7
A New Era in Pharmacovigilance: Toward Real-World Data and Digital Monitoring.药物警戒新纪元:迈向真实世界数据和数字化监测。
Clin Pharmacol Ther. 2021 May;109(5):1197-1202. doi: 10.1002/cpt.2172. Epub 2021 Feb 28.
8
Materiovigilance Programme of India: A scheme to assure cardiovascular devices safety surveillance.印度药物警戒计划:保障心血管器械安全监测的方案。
Indian Heart J. 2020 Jul-Aug;72(4):316-318. doi: 10.1016/j.ihj.2020.06.009. Epub 2020 Jul 1.
9
Materiovigilance: An Indian perspective.药物警戒:印度视角
Perspect Clin Res. 2018 Oct-Dec;9(4):175-178. doi: 10.4103/picr.PICR_26_18.
10
Development of a Classification Scheme for Examining Adverse Events Associated with Medical Devices, Specifically the DaVinci Surgical System as Reported in the FDA MAUDE Database.制定一种分类方案,用于审查与医疗器械相关的不良事件,特别是美国食品药品监督管理局不良事件报告数据库中所报告的达芬奇手术系统相关不良事件。
J Endourol. 2017 Jan;31(1):27-31. doi: 10.1089/end.2016.0396. Epub 2016 Dec 5.